AllPress MentionsLesaffre acquires Recombia Biosciences, a biotechnology company specialized in high-throughput genome editing and synthetic biologySeptember 7, 2022Read moreLesaffre and Recombia Biosciences to Advance Innovative Gene Editing Technology Through a Strategic PartnershipOctober 30, 2020Read more
